SPP1, secreted phosphoprotein 1, 6696

N. diseases: 824; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1096184
Disease: West Nile viral infection
West Nile viral infection
0.010 Biomarker disease BEFREE The overall results suggest that OPN facilitates WNV neuroinvasion by recruiting WNV-infected PMNs into the brain. 28680095 2017
CUI: C0043124
Disease: West Nile Fever
West Nile Fever
0.020 AlteredExpression disease BEFREE Our data suggests that OPN expression at early time points may provide protection against viral spread in the CNS by negatively controlling the type I IFN-sensitive, caspase 1-dependent inflammasome, while promoting an alternative caspase 8-associated pathway, to control the apoptosis of infected cells during WNV infection in the CNS. 28811681 2017
CUI: C0043124
Disease: West Nile Fever
West Nile Fever
0.020 Biomarker disease BEFREE Interestingly, WNV-infected OPN deficient (Opn <sup>-/-</sup>) mice exhibited a higher survival rate (70%) than wild type (WT) control mice (30%), suggesting OPN plays a deleterious role in WNV infection. 28680095 2017
Well Differentiated Hepatocellular Carcinoma
0.010 AlteredExpression disease BEFREE Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin. 23636305 2013
CUI: C0019562
Disease: Von Hippel-Lindau Syndrome
Von Hippel-Lindau Syndrome
0.010 AlteredExpression disease BEFREE Patients with VHL syndrome had significantly higher plasma OPN levels than healthy volunteers. 12538452 2003
CUI: C0042963
Disease: Vomiting
Vomiting
0.100 Biomarker phenotype HPO
Vitamin D-Resistant Rickets, X-Linked
0.030 Biomarker disease BEFREE Our findings of an excess of inhibitory OPN near osteocytes and their cell processes, and in dentin, spatially correlates with the defective mineralization observed at these sites in the skeleton and teeth of XLH patients. 27884786 2017
Vitamin D-Resistant Rickets, X-Linked
0.030 Biomarker disease BEFREE These data suggest that both MEPE and OPN are involved in impaired tooth mineralization associated with XLH, possibly through different effects on the mineralization process. 25158186 2014
Vitamin D-Resistant Rickets, X-Linked
0.030 Biomarker disease BEFREE Immunohistochemistry revealed altered OPN and DMP1 associated with an increased alkaline phosphatase staining in the XLH cultures. 28880715 2018
CUI: C0270824
Disease: Visual seizure
Visual seizure
0.200 Biomarker disease RGD Osteopontin in kainic acid-induced microglial reactions in the rat brain. 12132583 2002
CUI: C0042769
Disease: Virus Diseases
Virus Diseases
0.030 Biomarker group BEFREE We discovered species-specific colocalization of osteopontin with the follicular dendritic cell (FDC) network in lymphatic tissues in HIV-1 and simian immunodeficiency virus infections, and we found that changes in FDC-associated osteopontin covary with changes in lymphoid follicles during acute and late stages of infection and in response to treatment. 16136472 2005
CUI: C0042769
Disease: Virus Diseases
Virus Diseases
0.030 AlteredExpression group BEFREE Herein, we report on the role of osteopontin (OPN) in regulation of RSV infection in human epithelial cells and how interleukin-1 beta (IL-1β), a cytokine secreted soon after RSV infection, when persistently expressed can induce OPN expression leading to increased viral infection. 29677209 2018
CUI: C0042769
Disease: Virus Diseases
Virus Diseases
0.030 Biomarker group BEFREE Based on our findings of enhanced osteopontin (OPN) expression in inflamed human hearts, we further investigated in the murine model of acute and chronic coxsackievirus (CV)B3-myocarditis the role of OPN regarding its involvement in resolution of cardiac virus infection and fibrosis. 19246678 2009
CUI: C0042580
Disease: Vesico-Ureteral Reflux
Vesico-Ureteral Reflux
0.010 GeneticVariation disease BEFREE Renal scarring and osteopontin gene C/T polymorphism in children with primary vesicoureteral reflux. 22080623 2012
CUI: C0340279
Disease: Ventricular hypertrophy
Ventricular hypertrophy
0.010 AlteredExpression disease BEFREE The present study provides the first evidence that cardiomyocytes are a prominent source of OP in vivo and suggests that induction of OP expression is strongly associated with ventricular hypertrophy. 9386176 1997
CUI: C1402315
Disease: Vascular lesions
Vascular lesions
0.010 AlteredExpression disease BEFREE Fibrogenesis is associated with re-expression of embryonic preserved tissue developmental mediators: osteopontin (OPN), regulated by sex-determining region Y‑box 9 (Sox9), and homeobox A9 (HoxA9) play important roles in pathologic tissue remodeling and are upregulated in atherosclerotic vascular lesions; dickkopf-1 (DKK1) inhibits pro-fibrotic and atherogenic Wnt signaling. 28812103 2017
CUI: C0042373
Disease: Vascular Diseases
Vascular Diseases
0.020 Biomarker group BEFREE OPN could be considered a marker of vasculopathy and subclinical atherosclerosis in pediatric T1DM. 29687557 2018
CUI: C0042373
Disease: Vascular Diseases
Vascular Diseases
0.020 AlteredExpression group BEFREE With the recent finding that humans express multiple OPN isoforms as the result of alternative splicing and that these isoforms have distinct biologic functions, future studies are required to determine what OPN isoform(s) are expressed in the setting of vascular disease and what role each of these isoforms plays in vascular disease progression. 30727754 2019
CUI: C0342649
Disease: Vascular calcification
Vascular calcification
0.080 Biomarker phenotype BEFREE A variety of extracellular matrix molecules such as collagen type 1, bone sialoprotein, and osteopontin are known to regulate the biomineralization of bone and ectopic vascular calcification. 15472131 2004
CUI: C0342649
Disease: Vascular calcification
Vascular calcification
0.080 Biomarker phenotype BEFREE Osteopontin (OPN) is involved in mineral metabolism and the inflammatory response while diabetes mellitus is associated with severe and extensive vascular calcification. 27743892 2016
CUI: C0342649
Disease: Vascular calcification
Vascular calcification
0.080 Biomarker phenotype BEFREE Evidence from the literature suggests that OPN may fit within the Goldilocks paradigm with respect to cardiovascular disease, where acute increases are protective, attenuate vascular calcification, and promote postischemic neovascularization. 30727754 2019
CUI: C0342649
Disease: Vascular calcification
Vascular calcification
0.080 Biomarker phenotype BEFREE Interestingly, OPN may also possess potentially protective vascular effects, such as attenuation of vascular calcification. 25128758 2014
CUI: C0342649
Disease: Vascular calcification
Vascular calcification
0.080 Biomarker phenotype BEFREE The relationship of osteopontin (OPN) - which is known as a vascular calcification inhibitor - and fibroblast growth factor-23 (FGF-23) - which its related to vascular calcification, as recently shown - to valvular calcification is unknown. 30369401 2019
CUI: C0342649
Disease: Vascular calcification
Vascular calcification
0.080 Biomarker phenotype BEFREE Taken together, these demonstrated that OPN exerts an important role in the monocytes/macrophage phenotypic differentiation from hypertensive patients with VC, which includes reducing inflammatory factor expression and attenuating osteoclast formation. 28091516 2017
CUI: C0342649
Disease: Vascular calcification
Vascular calcification
0.080 Biomarker phenotype BEFREE Osteoprotegerin (OPG) and osteopontin (OPN) are involved in both VC and CKD. 29407881 2018